Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13610607 | 0.94 | TSHR (0.40) | TSHRUSP2MAPTCYP1A2CYP2C19 | |
| SCHEMBL9560795 | 0.84 | TSHR (0.44) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL9560780 | 0.84 | TSHR (0.44) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL9560553 | 0.84 | TSHR (0.44) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL13610617 | 0.84 | TSHR (0.35) | TSHRUSP2MAPTCYP1A2CYP2C19 | |
| SCHEMBL6259578 | 0.83 | TSHR (0.40) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL9560942 | 0.82 | MAPT (0.42) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL20867556 | 0.82 | TSHR (0.42) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL9560423 | 0.82 | MAPT (0.42) | TSHRUSP2MAPTCYP1A2CYP2C9 | |
| SCHEMBL9560591 | 0.82 | MAPT (0.42) | TSHRUSP2MAPTCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7623751-B2 | Compound, polymerizable composition, optical device, and method for producing refractive index profile optical device | FUJIFILM CORPORATION (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20080226244-A1 | Compound, Polymerizable Composition, Optical Device, and Method for Producing Refractive Index Profile Optical Device | FUJIFILM CORPORATION (JP) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080226244-A1 | Compound, Polymerizable Composition, Optical Device, and Method for Producing Refractive Index Profile Optical Device | PIEZO1, PFN1, INF2 | TSHR 2398/4885USP2 4518/4885MAPT 2002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.